or Try an Advanced Search...

    Dystrophy Stocks List

    Symbol Grade Name % Change
    IONS F Ionis Pharmaceuticals, Inc. 0.21
    BLUE F bluebird bio, Inc. 17.52
    FULC F Fulcrum Therapeutics, Inc. 9.43
    DYN F Dyne Therapeutics, Inc. -0.13
    SLDB F Solid Biosciences Inc. 3.44
    SRPT D Sarepta Therapeutics, Inc. 3.38
    SMMT D Summit Therapeutics plc 3.15
    WVE C WAVE Life Sciences Ltd. -0.56
    BNTC C Benitec Biopharma Limited 2.84
    TVTX B Travere Therapeutics, Inc. -0.05
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Muscular Dystrophy Biopharmaceutical Duchenne Muscular Dystrophy Duchenne Biotechnology Medicine Biology Disease Genetic Genealogy Medical Genetics Clinic Cystic Fibrosis Cytoskeleton Dystrophin Gene Expression Hepatitis B Hepatitis C Huntington's Disease Infectious Diseases Life Sciences

    Related ETFs - A few ETFs which own one or more of the above listed Dystrophy stocks.

    Symbol Grade Name Weight
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 9.3
    MEDX F Horizon Kinetics Medical ETF 9.09
    PPH D Market Vectors Pharmaceutical ETF 5.89
    MVAL A SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF 5.37
    RDIV A RevenueShares Ultra Dividend Fund 5.27
    View all Dystrophy ETFs...
    Compare ETFs
    Compare FTXH to MEDX Compare FTXH to RDIV Compare PPH to MVAL

        Dystrophy Stocks Recent News

        Date Stock Title
        Nov 22 SRPT High Growth Tech Stocks to Watch in November 2024
        Nov 22 DYN Dyne Therapeutics Inc. (DYN): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts
        Nov 21 IONS Why Is Ionis Pharmaceuticals, Inc. (IONS) Among the Worst Performing Biotech Stocks in 2024?
        Nov 20 SMMT Summit Therapeutics (SMMT) Hurt Bronte Capital. Here’s Why
        Nov 20 IONS Ionis Pharmaceuticals, Inc. (IONS): Among the Best Genomics Stocks to Buy Right Now
        Nov 18 IONS Here's Why Ionis Pharmaceuticals (IONS) is Poised for a Turnaround After Losing -13.46% in 4 Weeks
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Muscular Dystrophy Biopharmaceutical Disease Medicine Biotechnology Duchenne Duchenne Muscular Dystrophy Hepatitis B Hepatitis C Biology Cancer Clinic Cystic Fibrosis Diabetes Disorders Drug Discovery Dystrophin Facioscapulohumeral Muscular Dystrophy Gene Expression Genetic Genealogy
        Dystrophy

        Dystrophy is the degeneration of tissue, due to disease or malnutrition, most likely due to heredity.

        More about Dystrophy
        Browse All Tags